It was anything but a quiet August for healthcare M&A. Chris Wilson, a partner at Goodwin’s private equity group and co-chair of the healthcare practice, described a “tale of two cities.” Read The Deal article here.
Related Content
- Health HeadlinesMarch 28, 2025
Health Headlines: March 2025
- AlertMarch 20, 2025
States Continue to Pursue and Expand Healthcare Market Oversight at an Unprecedented Pace, With Significant Implications for Private Equity
- InsightFebruary 26, 2025
OIG Issues Two Favorable Advisory Opinions for Dental Supply Loyalty Program and Pharmaceutical Manufacturer Sponsor of Genetic Tests
- InsightFebruary 26, 2025
Aetna’s “Fraud Scheme” Lawsuit Against Radiology Group Highlights Health Plans’ Resistance to Private-Equity-Backed Providers
- Health HeadlinesFebruary 26, 2025
Health Headlines: February 2025
- AlertFebruary 20, 2025
First Circuit Adopts Defense-Friendly “But-For” Causation Standard for AKS-Predicated FCA Claims
- AlertFebruary 7, 2025
Navigating the Digital Health Frontier: Unpacking NYHIPA’s Far-Reaching Impact on Health Data Privacy
- Health HeadlinesJanuary 31, 2025
Health Headlines: January 2025
- In the PressApril 8, 2025
Healthcare M&A and Financing in 2025 (HealthcareMarkets)
- Awards and RankingsApril 7, 2025
Goodwin Is Top Law Firm for Global M&A for Q1 2025
- In the PressApril 2, 2025
Goodwin Grows Private Equity Practice With New SF Partner (Law360)
- EventsMarch 27, 2025
Goodwin’s Annual Healthcare & Life Sciences Summit
- Press ReleaseMarch 13, 2025
Goodwin Leads M&A, Private Equity, and Venture Capital League Table Rankings for 2024
- WebinarMarch 11, 2025
PE Implications of Recent Revisions to Massachusetts' Healthcare Transaction Review Law
- In the PressMarch 6, 2025
A Founder's Legal Playbook from a Healthtech Lawyer with Sophie McGrath, Partner at Goodwin (The HealthTech Podcast)
- In the PressJanuary 29, 2025
More States Weigh Curbs on Private-Equity Healthcare Investments (The Wall Street Journal)